RSV (Adults/Maternal)
RSV Vaccine — Adults and Maternal (Abrysvo/mRESVIA)
Platform: Prefusion F protein subunit / mRNA
Vaccine that protects older adults and newborns against respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections.
Immunology Sections
Curated section analysis in progress
Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.
Wikipedia Overview
Full article ↗A respiratory syncytial virus vaccine, or RSV vaccine, is an annual vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year.
PubMed Literature
Search PubMed ↗No PubMed results retrieved.
Semantic Scholar
Search S2 ↗No Semantic Scholar results retrieved.